<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="232605">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00048217</url>
  </required_header>
  <id_info>
    <org_study_id>T1249-105</org_study_id>
    <nct_id>NCT00048217</nct_id>
  </id_info>
  <brief_title>A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Trimeris</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Trimeris</source>
  <brief_summary>
    <textblock>
      Patients who complete study T1249-102 (must be currently failing a T-20 containing regimen
      to participate in this study) will receive T-1249 at a dose of 200mg daily in combination
      with a background antiretroviral regimen for 96 weeks. Only patients that participated in
      study T1249-102 can participate in study T1249-105.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <condition>HIV Infections</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>T-1249</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Completion T1249-102;

          -  Currently failing a T-20 containing regimen

        Exclusion Criteria:

          -  Non-completion of T1249-102.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Trimeris</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27707</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2004</verification_date>
  <lastchanged_date>June 23, 2005</lastchanged_date>
  <firstreceived_date>October 28, 2002</firstreceived_date>
  <keyword>Treatment Experienced</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
